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ONE HEALTH, ONE MEDICINE 
Laura H. Kahn, Thomas P. Monath, Bob H. Bokma, E. Paul Gibbs, 
and A. Alonso Aguirre 
In recognition that the health of humans, animals, and 
the environment is linked, One Health seeks to increase 
communication and collaboration across the disci-
plines in order to promote, improve, and defend the 
health of all species on the planet. This strategy may 
seem simple, but unfortunately it will not be easy to 
implement. The explosion of medical knowledge in the 
20th century led to academic, governmental, and 
industrial silos of specialization; these silos fostered a 
compartmentalized approach to health and disease. 
Building bridges across these silos will require leader-
ship, joint educational programs, financial support, and 
other strategies that promote transdisciplinary efforts. 
Before the 20th century, physicians typically 
worked with veterinary medical colleagues and others 
to improve the health of humans and animals. This 
chapter will describe the historical developments in 
medicine and veterinary medicine leading to the 
current status quo. It will provide examples of why 
the status quo is problematic and will highlight the 
challenges in changing the present paradigm. It will 
conclude with recommendations on how to imple-
ment a One Health approach in the future. 
HISTORICAL BACKGROUND 
Humans have been domesticating wild animals begin-
ning with dogs since 14,000 years Be (Trut 1999), 
developing agriculture, and altering the environment. 
In contrast to the harsh nomadic hunter-gatherer 
lifestyle, most humans preferred the secure and pro-
ductive lifestyle that agriculture allowed. However, 
this novel lifestyle introduced unanticipated health 
risks since aggregated crops and concentrated live-
stock altered the interactions of humans, domestic 
animals, wildlife, and ecosystems. Moreover, humans 
lived in close proximity to animals and sometimes 
shared living quarters (McNeill 1977 ). 
Small farming communities eventually grew into 
villages, towns, and cities, which concentrated humans 
into dense living conditions that facilitated the spread 
of microorganisms from individual to individual, 
allowing infectious disease epidemics to develop and 
propagate. As a result, infectious diseases, such as syl-
vatic plague, smallpox, cholera, and malaria, began to 
afflict humans, leading to epidemic morbidity and 
mortality (McNeill 1977 ). 
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Some of the diseases affecting agricultural and 
urbanized societies came from humans or livestock 
after domestication, such as bovine tuberculosis, rabies, 
and a wide array offood-borne bacterial and protozoan 
infections as transmissible zoonoses (Diamond 1999). 
In addition, wildlife served as reservoirs of innumera-
ble diseases that could be transmitted back to humans 
and domestic animals. For example, nearly one quarter 
to one third of the population of Europe was decimated 
by plague, also called "the Black Death" during the 
mid-14th century (Wheelis 2002). 
To complicate matters, people thought epidemics 
were caused by divine retribution for lapsed moral 
behavior, bad air "miasmas;' and demons and other 
spirit beings, among other etiologies (Conrad 1992j 
De Paolo 2006). These beliefs lasted for centuries, 
hindering effective preventive and control efforts. 
However, despite a lack of understanding of infectious 
diseases, some individuals developed effective control 
measures. 
For example, during the 18th century, rinderpest, 
a deadly viral disease of cattle, was devastating 
the human food supply. Pope Clement XI asked 
Dr. Giovanni Maria Lancisi, his personal physician, 
to combat the problem. Lancisi recommended that 
all of the ill and suspect animals be killed and buried 
in lime, since he suspected that the disease was 
communicable. His concept proved effective, and 
in 1762, the first school of veterinary (from the 
Latin "beast of burden") medicine was established in 
Lyon, France, to educate the next generation about 
the management of diseases in livestock (Palmarini 
2007 ). 
BEGINNINGS OF SClEl\"TIFIC 
BREAKTHROUGHS AND ONE 
HEALTH, ONE MEDICINE 
In 1827, Charles Darwin decided to leave medical 
school at the University of Edinburgh to pursue stud-
ies in religion and natural history at Cambridge 
University. Health practitioners in Darwin's time were 
routinely trained in natural history and zoology since 
these disciplines were closely aligned and were con-
sidered integral subjects in medical training. Darwin 
never completed medical school, but his experience 
aboard the HMS Beagle, and most likely his expo-
sure to multiple disciplines, led to his publishing his 
monumental book in 1859, On the Origin of Species 
(Leff 2000). 
Rudolf Virchow (1821-1902), the German physi-
cian and pathologist, coined the term "zoonosis" and 
said, "between animal and human medicine there are 
no dividing lines-nor should there be:' He strongly 
supported veterinary medicine and advocated for 
public health meat inspections throughout Europe. 
The United States eventually adopted meat inspec-
tions as well. This novel practice served as the basis 
for modern-day public health meat and poultry 
inspections by veterinarians (Kahn et aL 2007). 
Sir William Osler (1849-1919), first Professor of 
Medicine at Johns Hopkins Hospital and considered 
the "father of modern medicine;' had traveled from 
Canada to Germany to study with Virchow. Virchow 
impressed upon his student the importance of autop-
sies, pathology, and scientific methodologies. Osler 
returned to Canada to teach parasitology, physiology, 
and pathology at the Montreal Veterinary College, 
which eventually became affiliated with the medical 
school at McGill University. At the veterinary college, 
Osler researched hog cholera (classical swine fever), 
Pictou cattle disease caused by tansy ragwort (Senecio 
jacobaea) intoxication, which was believed to be a 
microbial infection at that time, and verminous bron-
chitis of dogs, among others. He worked closely with 
veterinarians such as Albert W Clement, who became 
the President of the United States Veterinary Medical 
Association (USVMAj Kahn et al. 2007). 
Louis Pasteur (1822-1895) and Robert Koch (1843-
1910) changed the course of history by discovering 
that microscopic organisms caused disease. This 
knowledge allowed the development of effective pre-
ventive and control measures against pathogens. 
Pasteur developed a vaccine against rabies, and Koch 
discovered that Clostridium tetani caused tetanus, 
Streptococcus pneumoniae caused pneumonia, and 
Vibrio cholerae caused cholera (Munch 2003). 
The advances in scientific knowledge spurred 
efforts to improve medical education. The American 
Medical Association (AMA) invited the Carnegie 
Foundation for the Advancement of Teaching to 
conduct a study on the status of medical education in 
the United States. In 1910, Abraham Flexner published 
the report that recommended that medical education 
be modeled after that at Johns Hopkins University, 
which emphasized a scientific approach to medical 
education and patient care. The ultimate effect of 
incorporating medical schools into universities was 
the emphasis on training medical specialists rather 
than general practitioners (Starr 1982). 
The idea of an American veterinary profession 
was supported by agricultural societies and by physi-
cians such as Benjamin Rush and Andrew Stone. 
Before the 1880s, most school-trained veterinarians 
were trained in Europe. The development of veteri-
nary schools in the United States arose from concerns 
over animal disease epidemics following the Civil War 
and the interest in scientific agriculture signaled by 
the Morrill Land Grant Act of 1862, which provided 
federal funding to establish the first college-affiliated 
veterinary school at Iowa State University in 1879. 
The curriculum derived from agriculture and veteri-
nary medicine. The University of Pennsylvania's 
School of Veterinary Medicine opened in 1884 and 
was the first accredited veterinary medical college in 
the United States whose origin was in medicine rather 
than agriculture. 
By the late 19th century, a web of veterinary institu-
tions, organizations, and periodicals were established, 
including the USVMA, founded in 1863 and renamed 
the American Veterinary MedicalAssociation (AVMA) 
in 1898; the Bureau of Animal Industry (BAI), created 
in 1884 in the U.S. Department of Agriculture (USDA) 
and headed until 1905 by veterinarian Daniel E. 
Salmon; and the American Veterinary Review, begun in 
1877 and renamed the Journal oftheAmerican Veterinary 
Medical Association in 1914-1915. 
BAI veterinarians Fred L. Kilbourne and Cooper 
Curtice and physician Theobald Smith first demon-
strated the role of vectors in the transmission of animal 
diseases. The BAI also certified and employed veteri-
narians in food inspection and influenced veterinary 
medical school curricula. Between the 1880s and 1925, 
graduate veterinarians sponsored state laws creating 
examining boards and setting graduation and licens-
ing requirements .. In late 19th and early 20th centuries, 
Leonard Pearson, a bovine tuberculosis expert, 
directed attention to the relationship between animal 
and human health (Palmer and Waters 2011). 
As the 20th century progressed, physicians became 
increaSingly specialized and collaborative efforts 
with veterinarians waned. Human and animal diseases 
Were largely treated as separate entities. However, 
a few veterinarians, such as Calvin W. Schwabe (1927-
2006), the renowned veterinary epidemiologist and 
paraSitologist, continued to promote a unified human 
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and veterinary approach to zoonotic diseases by 
publishing his book Veterinary Medicine and Human 
Health (Schwabe 1984). 
This need to work together has not diminished 
despite the professions drifting apart. Since 1940, 
over 330 infectious diseases have emerged from ani-
mals into human populations (Taylor et al. 2001). The 
threat to global health is increasing since human pop-
ulation density] the most significant independent 
predictor of disease emergence, continues to increase 
(Jones et al. 2008). Indeed, it is estimated that by 2050, 
the human population will reach 9 billion (United 
Nations 2007). 
Human activities such as deforestation, intensive 
agriculture, bushmeat consumption, waste produc-
tion, and greenhouse gas emissions will only intensify 
as growing populations demand more food, water, 
clothing, shelter, and energy. For example, surveil-
lance of fruit bat health and behavior in Malaysia 
might have helped prevent the disaster that developed 
in 1998-99 after extensive deforestation destroyed 
the fruit bat's habitat. Millions of hectares of tropical 
rain forest were slashed and burned to make way for 
pig farms. Fruit bats (the natural reservoir of the 
virus), whose habitat was largely destroyed by defor-
estation, sought nourishment from fruit trees near 
the pig farms and subsequently spread the virus to 
livestock. The subsequent Nipah virus outbreak dem-
onstrates that destruction of wildlife habitats has an 
adverse impact on livestock and human health. In this 
case, the flowering and fruiting trees that the fruit 
bats relied on for their survival were destroyed to 
make room for pig farms. The bats resorted to con-
suming fruit located next to the farms. Pigs ate the 
partially eaten fruit that had been contaminated by 
bat saliva and urine. The bats harbored the Nipah 
virus, a previously unknown pathogen. The economic 
and human health impact of the outbreak was severe: 
the pig farmers lost millions, and pig farming in the 
country largely collapsed and is now allowed in only 
approved areas. This set off a chain reaction that 
ultimately led to the development of encephalitis in 
hundreds of humans and over 100 fatalities (Kahn 
2011). 
The magnitude of the problem illustrates why 
human medicine, veterinary medicine, and ecology 
need to rejoin forces. Taylor et aI. (2001) identified 
lA15 infectious agents and determined that 868 (61%) 
were zoonotic. They found that zoonotic diseases 
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were twice as likely to be newly emerged infections 
compared to other diseases. RNA viruses, in particu-
lar, are highly likely to emerge from animals and cross 
species barriers because they are subject to rapid 
mutagenesis and can readily adapt to new hosts and 
vectors. Examples include West Nile virus (WNV), 
avian influenza virus, SARS coronavirus, arenaviruses, 
and hantaviruses (Cleaveland et al. 2001). 
CHALLENGES AND 
OPPOHTUNITIES OF 
IMPLEMENTING A NEW 
PARADIGM 
A new paradigm requires that human, animal, and 
ecosystem health be addressed equally, equitably, and 
expeditiously. Ironically, to address future threats, we 
need look no further than what the medical and scien-
tific luminaries of the 19th century developed: the 
One Health concept. The One Health concept seeks 
to integrate human, animal, and ecological health in 
clinical practice, public health, scientific research, and 
policy. Some professional organizations have recog-
nized the importance of this paradigm. In September 
2004, experts at the Wildlife Conservation Society 
held a "One World, One Health" conference in New 
York City that led to the "Manhattan Principles" call-
ing for an international, interdisciplinary approach 
to protect life on the planet (Cooketal. 2004). InJune 
2007, the AMA House of Delegates unanimously 
approved a "One Health" resolution following AVMA 
input endorsing interdisciplinary collaboration with 
AVMA (Kahn et al. 2008). Then AVMA approved 
a similar "One Health" resolution (JAVMA, 2009). 
Other organizations that have endorsed the One 
Health concept include the American Society of 
Tropical Medicine and Hygiene, the Society for 
Tropical Veterinary Medicine, the American Society 
for Microbiology, and the Council of State and 
Territorial Epidemiologists. 
The mission statement for the "One Health" 
initiative states: "Recognizing that human and animal 
health are inextricably linked, 'One Health' seeks 
to promote, improve, and protect the health and 
well-being of all species by enhancing cooperation 
and collaboration between physicians, veterinarians, 
epidemiologists, public health professionals and allied 
health scientists by promoting strengths in leadership 
and management to achieve these goals:' Three over-
arching goals are enhancing public health effective-
ness, understanding anthropogenic changes and the 
emergence of new pathogens of animal and human 
origin, and accelerating biomedical research discover-
ies, including advances in clinical medical and surgical 
approaches. In June 2009, the AVMA's One Health 
Commission was incorporated with the mission of 
developing strategies to put the One Health concept 
into practice. The challenges are many, but the rewards 
would be a healthier future for humans, animals, and 
the Earth's ecosystems. 
A similar approach was expounded by Aguirre 
et al. (2002), who emphasized the need to bridge 
disciplines, thereby linking human health, animal 
health, and ecosystem health under the paradigm 
that "health connects all species on the planef' 
Conservation medicine embraces the One Health 
concept by applying a transdisciplinary approach 
to the study of the health relationships between 
humans, animals, and ecosystems. Conservation med-
icine is closely allied with and primarily concentrates 
on the values of conservation biology by recognizing 
that health and disease are fundamentally related to 
the integrity of ecosystems. Therefore, it draws on the 
principles of both ecology and applied medicine in its 
approach to health and disease. The international 
peer-reviewed journal EcoHealth was launched in 
2004 and focuses on the integration of knowledge 
at the interface between ecological, human, and 
veterinary health sciences and ecosystem sustainabil-
ity. This publication, among others, links disciplines 
and focuses attention toward "One Health, One 
Medicine" (Bokma et al. 2008; Mackenzie and Jeggo 
2011). 
CHALLENGES AND 
OPPORTUNITIES IN MEDICINE 
AND VETERTNAHY MEDICINE 
There are a number of challenges in implementing the 
One Health concept in human and veterinary medical 
education and practice. First, worldwide there are 
a disproportionate number of accredited medical 
schools compared to veterinary medical schools. 
There are 125 accredited medical schools compared 
to only 29 veterinary medical schools in the United 
States, and only a handful of them share campuses. 
Globally, there are approximately 2,161 medical schools 
operating in 172 countries as of 2009. These interna-
tional medical schools, recognized by their respective 
governments, might not necessarily meet each other's 
standards (Bokma et al. 2008; Foundation for 
Advancement of International Medical Education and 
Research 2009). 
There are five colleges of veterinary medicine in 
Canada (four fully accredited and one with limited 
accreditation) and 29 in the United States (25 fully 
accredited and four with limited accreditation) 
fulfilling AVMA standards. In addition, the AVMA 
Educational Commission for Foreign Veterinary 
Graduates (ECFVG) Veterinary Schools of the World 
lists 471 colleges of veterinary medicine and animal 
sciences in 109 countries. The majority have either not 
been evaluated by the AVMA or do not have compa-
rable standards to meet A VMA accreditation, and only 
nine (Australia [three], Scotland [two], and England, 
Ireland, Netherlands, and New Zealand) fulfillAVMA 
standards. 
The ECFVG does not represent this as a compre-
hensive list of all veterinary schools in the world. For 
example, Brazil has 46 veterinary colleges listed, but as 
of September 2009 there are more than 108 schools, 
and this may be the case for other countries. The A VMA 
list includes all schools listed by the World Health 
Organization in its 1991 World Veterinary Directory 
and in the 1983 Pan American Health Organization 
publication Diagnosis of Animal Health in the Americas. 
The list includes additional schools that have come 
to the attention of the ECFVG for reasons related to 
certification. 
Why would foreign medical and veterinary medi-
cal colleges want to comply with AMA or AVMA 
standards? Global needs differ. For example, cattle 
production and intensification have been major 
concerns in developing countries. In contrast, in the 
developed world, canine medicine and exotic medi-
cine have been of primary interest. Unless interna-
tional educational standards are developed, it might 
be hard to convince many countries to accept U.S. 
standards as a baseline. 
From a purely logistical standpoint, increasing 
communication and collaboration between students 
of these professions would be difficult since there are 
not as many schools of veterinary medicine, and of 
those that exist, relatively few are close enongh to 
medical schools to facilitate meaningful educational 
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and collaborative efforts. During 2009, the World 
Animal Health Organization ( 0 IE) released Veterinary 
Education for Global Animal and Public Health (Walsh 
2009), which is devoted to the improvement of 
student education in global animal and public health. 
The main concern expressed by this and other publi-
cations is to determine how this education can be 
achieved within an already packed curriculum. 
One solution might be to establish One Health 
Institutes in various geographic locations globally that 
would bring together medical and veterinary medical 
students for cross-species disease teaching, informa-
tion-sharing, and problem-solving. For example, the 
Centers for Disease Control and Prevention (CDC) 
established a One Health program, and two veterinary 
colleges (UC-Davis and UM-Minneapolis) have 
established One Health programs within their curric-
ulum. The trend continues to grow, and these partner-
ships may encourage medical and veterinary medical 
schools to establish "sister" institutional ties and allow 
their students to spend elective time at the designated 
sister school for courses not available at their home 
institution. 
This arrangement could facilitate building bridges 
and filling gaps in areas that medical and veterinary 
medical schools might not emphasize. For example, 
medical schools do not emphasize public and envi-
ronmental health, exotic pathogens, or the ecology of 
zoonotic diseases. In contrast, veterinary medical 
teaching is much more concerned with exotic patho-
gens (which threaten livestock if introduced), diseases 
affecting multiple species, and the effects of environ-
mental health on livestock production. The lack of 
teaching of zoonoses in medical schools might explain 
why physicians are generally not comfortable discuss-
ing zoonotic disease risks with their patients (Grant 
and Olsen 1999). 
Evidence suggests that infectious agents can 
jump from animals to humans and vice versa (Childs 
et al. 2007; CDC 2008). One bacterium of particular 
concern is methicillin-resistant Staphylococcus aureus 
(MRSA), which causes serious community-acquired 
soft-tissue and skin infections (Fridkin et al. 2005), as 
well as hospital-acquired infections and deaths (Klein 
et al. 2007). Scott et al. (2009) found that households 
with cats were almost eight times more likely to have 
MRSA on one or more household surfaces than those 
without cats. Members of the households in the study 
did not have a history of infections or antibiotic use. 
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The authors recommended that further study was 
needed to determine if MRSA cross-contamination 
was occurring between humans, pets, and household 
surfaces. Studies assessing pathogen transmission in 
home settings are critical for furthering our under-
standing of microbial dynamics and would help 
in developing strategies to reduce disease. Since 
millions of families own pets or share their homes 
with animals, research to prevent the spread of patho-
gens in homes should be given priority, especially 
since many pathogens are developing antibiotic 
resistance. 
CHALLENGES AND 
OPPORTUNITIES iN 
PUBLIC HEALTH 
The WNV outbreak in New York City highlights why 
disease surveillance of animals is as important as 
disease surveillance in humans in protecting public 
health. This outbreak illustrates that government 
agencies must seamlessly integrate human and animal 
disease surveillance efforts. In late May 1999, residents 
in Queens, New York, noticed dead and dying birds, 
and some were brought to the local veterinary clinic. 
The veterinarians noted that the birds had unusual 
neurological signs; unfortunately, no local or state 
agency took responsibility for the large wildlife die-
off, so nothing was done to determine why these ani-
mals were dying (US. General Accounting Office 
2000). A month later, an infectious disease specialist 
at Flushing Hospital admitted eight patients with 
encephalitis. Three patients died and CDC found 
that their brain tissue contained flavivirus antigen. 
These were later confirmed as the first human cases 
of WNV in the Western Hemisphere (Asnis et al. 
2000). 
Before and concurrent with the human disease 
outbreak, exotic birds at the Bronx Zoo were noted 
to have died. The veterinary pathologist noted that 
the birds exhibited tremors, loss of coordination, and 
convulsions. Upon necropsy most birds had brain 
hemorrhages and/ or meningitis similar to the human 
cases. Tissues from these birds were sent to the 
USAMRIID laboratories, where isolated viruses were 
sent to CDC, and WNV was diagnosed by PCR and 
DNA sequencing (CDC 1999). Concurrently, a group 
of investigators at the University of California at Irvine 
also used molecular techniques to show that the 
offending agent was WNV (Briese et al. 1999). This 
was the first time that the virus had appeared in 
the Western Hemisphere (Mahon 2003). 
In response to WNV emergence, CDC established 
ArboNET, a cooperative surveillance system that 
monitors the geographic spread ofWNV in mosqui-
toes, birds, other animals, and humans (Marfin et al. 
2001). ArboNET has provided an invaluable system 
for tracking the spread of WNV across the United 
States and identifying early activity in mosquitoes and 
birds (CDC 2008). This surveillance system demon-
strates that monitoring disease activity in arthropod 
vectors, animals, and humans is invaluable in tracking 
zoonotic disease spread and in developing successful 
containment and preventive strategies. 
Unfortunately, surveillance of zoonotic diseases 
on a wider scale might be more difficult to implement. 
In the United States, reporting of animal diseases 
varies from state to state. Some states have one agency, 
typically departments of agriculture, responsible for 
domestic animal disease surveillance, while others 
split reporting of animal diseases between different 
agencies. Wildlife on non-federal lands in the United 
States is generally owned by the states. In some states, 
local public health agencies are supposed to receive 
reports of zoonotic diseases, primarily rabies, from 
veterinarians (Kahn 2006). 
At the national level, surveillance of animal health 
is hindered because responsibility is split between 
many different government agencies: USDA, US. 
Department of Health and Senior Services, US. 
Department of Interior, US. Department of Home-
land Security (USDHS), and US. Department of 
Commerce (National Academy of Sciences 200S). 
The USDA's Animal and Plant Health Inspection 
Service (APHIS) is the lead agency for livestock 
health and compiles disease surveillance data that are 
reportable to Food and Agriculture Organization 
(FAO) and OlE. However, there is no comparable 
CDC for all animals, including pets, wildlife, and zoo 
animals, so there are no comprehensive data available 
like in human disease surveillance. 
At the federal level, one agency is primarily respon-
sible for human health: the US. Department of Health 
and Human Services (USDHS). The USDHS has 
a subsidiary role in human health, and the US. 
Department of Defense provides support in times 
of crisis, such as USAMRIID laboratory expertise 
during the WNV crisis. State and local governments 
have primary responsibility for disease surveillance in 
humans, and they vary in infrastructures and capa-
bilities (Institute of Medicine 2003). They provide 
data to the CDC, which compiles the information 
on a regular basis. The CDC serves primarily as a 
resource for state and local health departments. The 
USDA is in charge of domestic animal and captive 
wildlife health; however, several agencies are respon-
sible for wildlife, depending on the animal's status 
as a migratory or non-migratory species. 
Animal health and disease surveillance are also 
fragmented at the international leveL WHO has 
primary responsibility for human health and has a 
significant presence in UN member countries. The 
mission ofFAO is to promote agriculture and alleviate 
hunger and offers limited animal health expertise 
to member countries. The OIE has animal health 
expertise, but has only a 40-person staff and no 
specific country presence (Institute of Medicine 
2009). The OIE's primary role is in the coordination 
of information, and it has an early warning system 
for member countries. It does not have the mandate 
to be physically present in countries or supportive in 
terms of funding. These three entities are the primary 
players in global domestic animal health. Although 
they work together, their different missions, functions, 
and levels of support limit collaborative efforts. For 
example, since the OIE is not part of the UN and has 
a small staff and budget, it does not have the capacity 
to assume a role analogous to WHO's role for human 
health. Furthermore, none of the three has significant 
staff or resources focused on wildlife or ecosystem 
health. 
The Institute of Medicine (2009) recognized that a 
lack of comprehensive, integrated human and animal 
disease surveillance systems, both in the United States 
and internationally, impedes an early warning system 
of emerging zoonotic diseases. International systems 
need surveillance programs and diagnostic laboratory 
capacities, but these are limited in developing coun-
tries, where most of the zoonotic diseases have 
emerged. A centralized coordinating body would be 
important in developing, harmonizing, and imple-
menting integrated international human and animal 
health surveillance activities. 
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CHALLENGES AND 
OPPORTUNITIES IN 
ECOLOGICAL HEALTH 
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The importance of ecological health was illustrated 
by the highly pathogenic avian influenza (HPAI) 
HsNI outbreak in Hong Kong in 1997. Surveillance 
of wild waterfowl and domestic poultry in southern 
China during the preceding decades facilitated the 
early recognition of the virus in humans (Shortridge 
et al. 2003). In May 1997, HSNI was isolated in a 
three-year-old boy who died of acute pneumonia 
respiratory distress syndrome (ARDS) and Reye 
syndrome. The isolation of this distinct avian virus 
subtype from a human signaled the beginning of 
a potentially deadly pandemic (deJong et al. 1997). 
By December 1997, the outbreak prompted slaughter-
ing of all poultry in Hong Kong and introducing 
import control of poultry from mainland China, 
supervised cleaning of poultry farms, and increased 
surveillance of disease spread in humans and birds 
(Tam 2002). 
These actions halted the outbreak. Unfortunately, 
six years later, the virus reappeared in humans in the 
Fujian province of China (Writing Committee of 
the WHO Consultation on Human Influenza 2005). 
In Southeast Asia, HsN 1 outbreaks began in December 
2003, devastating the poultry industries in the affected 
countries (Kuiken et al. 2005; see Chapter 16 in this 
volume). From 2003 to September 2009, a total of 
442 laboratory-confirmed human cases were reported 
from IS countries, with 262 (60%) fatalities (WHO 
2009). Pathogen surveillance in wildlife was minimal 
to non-existent. Kuiken et al. (2005) recommended 
a joint expert working group to design and implement 
a global animal surveillance system for zoonotic 
pathogens. In November 2005, FAO, OIE, WHO, and 
World Bank officials met to discuss the worsening 
HSNI HPAI crisis and agreed that surveillance sys-
tems for human and animal influenza were critical 
for effective responses. Veterinary infrastructures in 
many countries needed to be assessed and strength-
ened to meet OIE standards, countries needed to 
improve their laboratory and rapid response capabili-
ties, and funding and investments in these efforts were 
urgently needed (Jong-Wook 2005). 
In 2006, two animal surveillance systems were 
launched: the Global Early Warning and Response 
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System for Major Animal Diseases including Zoonoses 
(GLEWS) and Global Avian Influenza Network for 
Surveillance (GAINS). The revised 2005 International 
Health Regulations (IHR) require nations to notify 
WHO, within 48 hours, of all events that might con-
stitute a public health emergency of international 
concern. WHO also has a Global Outbreak Alert and 
Response Network (GOARN) that shares technical 
expertise, supplies, and support to help coordinate 
outbreak response investigations. Similar to the IHR 
legal framework supporting WHO's central role in 
collecting global public health information, the OlE's 
Terrestrial Animal Health Code requires that member 
countries notify OlE within 24 hours of an animal 
disease event of international concern. FAO has an 
early warning system, Emergency Prevention System 
for Transboundary Animal Diseases (EMPRES), 
established in 1994, that collects data from a variety 
of sources, including from OlE, to monitor for events 
of concern. The goal of GLEWS is to combine the 
WHO, OlE, and FAO data collection systems into a 
joint effort to facilitate communication and collabora-
tion between human and animal health. 
Unlike GLEWS, GAINS conducts active surveil-
lance of all strains of avian influenza in wild bird 
populations. Sponsored by the U.S. Agency for Inter-
national Development (USAID) and the CDC, 
GAINS started in 2006 and is administered by the 
Wildlife Conservation Society. Dozens of partner 
institutions collaborate in the GAINS network to 
survey wild bird populations and collect and analyze 
samples from wild birds either non-invasively or from 
capture and release. All data, including denominator 
data, species and sample ownership, are publicly avail-
able via a shared, open database. This early warning 
system allows health officials to understand the dis-
tribution of influenza viruses as well as wild birds in 
country and in neighboring countries. 
Much more should be done to monitor diseases 
in wildlife and domestic animals. There is no one 
international governmental agency that conducts 
comprehensive ecological surveillance and monitor-
ing of diseases in animals (Karesh and Cook 2005). 
Even worse, many wild animals are exported from 
countries that conduct little or no surveillance of the 
pathogens they might harbor (Marano et al. 2007). 
In response to a monkey pox outbreak introduced 
in the United States by importation of Giant Gambian 
rats (Cricetomys sp.), the CDC and the U.S. Food and 
Drug Administration (FDA) jointly issued an order 
prohibiting the importation of Mrican rodents and 
banned the sale, transport, or release of prairie dogs or 
six specific genera of Mrican rodents in the United 
States. The joint order was subsequently replaced by 
an interim final rule, which maintains the restrictions 
on African rodents, prairie dogs, and other animals. 
Unfortunately, the global trade in wildlife continues 
and poses serious threats to infectious disease ecology 
(GLEWS 2006; Smith et al. 2009; see Chapter 11 in 
this volume). There are many challenges of improving 
ecological health through disease surveillance of wild-
life. A One Health approach involving many parties, 
including human and animal health professionals, 
modelers, ecologists, sociologists, anthropologists, 
and others, would help provide comprehensive, coor-
dinated, and cohesive strategies in addressing this 
immense problem. 
CHALLENGES AND 
OPPORTlJNITIES IN 
BJOMEDlCAL RESEARCH 
Society would benefit if more biomedical research 
was done in comparative medicine. Comparative 
medicine is not a new academic discipline: the first 
chair was established in 1862 in France (Wilkinson 
1992). Comparative medicine is the study of the 
anatomical, physiological, pharmacological, microbi-
ological, and pathological processes across species. 
A long history of collaborations between veterinarians 
and physicians has been documented. For example, 
in the 20th century, Dr. RolfZinkernagel, a physician, 
and Dr. Peter Doherty, a veterinarian, won the 1996 
Nobel Prize in physiology or medicine for their 
discovery of how normal cells are distinguished from 
Virus-infected cells by a body's immune system 
(Zinkernagel and Doherty 1974). These discoveries 
illustrate that cross-disciplinary collaborations help 
generate new scientific insights in disease. 
Unfortunately, evidence suggests that the next 
generations of physicians and veterinarians are not 
collaborating with each other, and they are losing 
interest in pursuing careers in research. From 1970 to 
1997, the number of physician-scientists receiving 
National Institutes of Health (NIH) grants dimin-
ished in proportion to doctoral recipients who seek 
and obtain funding (Rosenberg 1999). Compared to 
the 1980s, there are now 25% fewer physician-scientists 
in medical school faculties (Varki and Rosenberg 
2002). To counter these trends, the NIH in 2002 
established a series of competitive loan repayment 
programs that provide at least two years of tax-free 
debt relief for young physician-scientists committed 
to clinically oriented research training. Private foun-
dations, such as Burroughs-Wellcome and the Howard 
Hughes Medical Institute, have created awards for 
new physician-scientists engaged in patient-oriented 
research. Some hospitals and medical schools are 
creating programs to encourage medical students 
to pursue research before and after receiving their 
medical degrees (Ley and Rosenberg 2005). 
The situation is dire for veterinarian-scientists. 
A 2004 National Academy of Sciences (NAS) report 
found that the total number of veterinarians who 
received NIH grant support is small. In 2001, veteri-
narian principal investigators received only 4.7% of 
all NIH grants for animal research, since the NIH does 
not fund veterinary research, only research that is 
of benefit to humans. An apparent consequence of 
the lack of research funding available to veterinarians 
is that less than 1% of AVMA members are board-
certified in laboratory animal medicine and less than 
2% are board-certified in pathology (National 
Research Council 2004). Much could be done to 
reverse these trends. First, NIH and private founda-
tion support for young physicians and veterinarians 
interested in pursuing research careers must be 
strengthened. Nowhere in the NIH's plans to improve 
biomedical research in the 21st century are compara-
tive medicine and the importance of veterinarians 
mentioned, even though one of its primary goals is 
to foster interdisciplinary research, encouraging new 
pathways to discovery (Zerhouni 2003). The NIH 
must recognize that animal health influences human 
health and must be supported accordingly. Jointly 
sponsored comparative medicine research grants from 
the National Center for Research Resources (NCRR) 
and other institutes, such as the National Institute 
of Allergy and Infectious Diseases (NIAID) and the 
National Cancer Institute, should be offered to medi-
cal and veterinary medical research teams to promote 
collaborative efforts (National Research Council 
2oosa,b). Further, some veterinary education reim-
bursement funding has recently been made available 
by the U.S. government in the National Veterinary 
Medical Service Act for veterinarians who decide to 
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go into government positions (http://www.avrna. 
org/ advocacy / avma _ advocate/jan09/ aa ~an09b.asp 
andhttp://www.avrna.org/fsvm/ AnimalHealthcare% 
2O(2).pdf). Also some states have begun offering vet-
erinary student loan repayment programs (notably 
Ohio; http://ovmlb.ohio.gov/sl.stm).AnewNational 
Veterinary Medical Service Act will improve loan 
repayment options for graduating veterinarians who 
choose to work in certain areas that affect animal or 
public health (http://www.avrna.org/press/releases/ 
100420_ VMLRP.asp) 
DEVELOPMENT OF NEW DRUGS 
AND VACCINES BY INDUSTRY 
The pharmaceutical industry provides many examples 
of unnecessary separation of human and veterinary 
medicine that provide impediments to progress. 
Typically the animal and human health divisions of 
pharmaceutical companies are physically and opera-
tionally divided. The regulatory requirements and 
review of products for human and veterinary health 
also lie in separate divisions of the FDA and USDA. 
Since physiological and pathological underpinnings 
of product development are generally shared across 
species, there would be much to gain from a close 
interaction between those engaged in research and 
development of animal and human health products. 
On the positive side, a few enlightened programs 
have reached in this direction. For example, when 
Akso Nobel created a new division devoted to devel-
opment of human vaccines, it integrated scientists 
from its veterinary health division (Intervet). Intervet 
and a human vaccines biotechnology company 
(Acambis) collaborated on the development of vac-
cines against WNv. The veterinary vaccine is now 
commercially available (Prevenile") and the human 
vaccine is in late stages of clinical testing. The deve-
lopment of these products required a close working 
relationship between scientists at both companies. 
THE FUTURE 
The One Health concept has languished too long 
in the 20th and 21st centuries in clinical care, public 
and ecological health, and biomedical research. 
Civilization is facing many threats, including Imman 
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overpopulation, the destruction of ecosystems, 
climate change, and emerging zoonotic pathogens. 
The combined, synergistic creativity and insights 
of transdisciplinary teams comprising physicians, 
veterinarians, ecologists, public health professionals, 
and others are needed to address these challenges. 
The organizational, institutional, and financial 
obstacles to implementing a global One Health 
approach to disease threats must not be ignored. It is 
incumbent upon the leaders in medicine, veterinary 
medicine, science, ecology, and public health to alert 
and educate political leaders, policymakers, the media, 
and the public about this critical approach in global 
health. Implementing a One Health approach globally 
would significantly mitigate or possibly avert future 
health crises. 
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